Total Payments
$183,065
2024 Payments
$7,135
Companies
57
Transactions
1,524
Medicare Patients
9,709
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$117,128 (64.0%)
Food & Beverage$35,390 (19.3%)
Consulting$19,009 (10.4%)
Travel$11,097 (6.1%)
Education$441.10 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,128 | 52 | 64.0% |
| Food and Beverage | $35,390 | 1,420 | 19.3% |
| Consulting Fee | $19,009 | 7 | 10.4% |
| Travel and Lodging | $11,097 | 30 | 6.1% |
| Education | $441.10 | 15 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $88,194 | 116 | $0 (2019) |
| ABBVIE INC. | $34,825 | 333 | $0 (2024) |
| Amgen Inc. | $29,727 | 210 | $0 (2024) |
| MEDAC PHARMA, INC. | $6,648 | 29 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $3,541 | 72 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $2,339 | 13 | $0 (2024) |
| Lilly USA, LLC | $2,156 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $1,836 | 90 | $0 (2024) |
| PFIZER INC. | $1,703 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,605 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,135 | 246 | Janssen Scientific Affairs, LLC ($1,230) |
| 2023 | $6,370 | 249 | ABBVIE INC. ($1,114) |
| 2022 | $11,144 | 213 | Amgen Inc. ($7,182) |
| 2021 | $7,195 | 194 | Amgen Inc. ($3,303) |
| 2020 | $8,196 | 67 | Amgen Inc. ($6,081) |
| 2019 | $49,506 | 225 | Celgene Corporation ($23,069) |
| 2018 | $40,426 | 142 | Celgene Corporation ($30,533) |
| 2017 | $53,093 | 188 | Celgene Corporation ($34,592) |
All Payment Transactions
1,524 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Fresenius Kabi USA, LLC | Tyenne (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Biosimilars | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: OSTEOPOROSIS | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology | ||||||
| 12/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Analgesic | ||||||
| 12/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $28.66 | General |
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.11 | General |
| 11/18/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,962 | 8,125 | $1.2M | $424,563 |
| 2022 | 30 | 2,528 | 6,945 | $1.4M | $513,777 |
| 2021 | 27 | 2,484 | 7,049 | $1.4M | $546,330 |
| 2020 | 18 | 1,735 | 4,640 | $906,402 | $312,051 |
Total Patients
9,709
Total Services
26,759
Medicare Billing
$1.8M
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 385 | 3,084 | $616,900 | $231,349 | 37.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 339 | 977 | $48,850 | $26,574 | 54.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 90 | 98 | $39,200 | $16,869 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 157 | $39,300 | $16,508 | 42.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 125 | 138 | $34,500 | $13,811 | 40.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 52 | 55 | $33,000 | $12,138 | 36.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 167 | 922 | $92,200 | $11,279 | 12.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 99 | 112 | $33,600 | $11,118 | 33.1% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 92 | 101 | $35,350 | $10,634 | 30.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 50 | 52 | $20,800 | $8,413 | 40.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 43 | 45 | $18,000 | $7,688 | 42.7% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 70 | 137 | $34,250 | $6,262 | 18.3% |
| 72082 | X-ray of entire middle and lower spine, 2-3 views | Office | 2023 | 81 | 86 | $30,100 | $5,418 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,600 | $4,986 | 39.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 252 | 475 | $7,125 | $3,990 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 25 | $11,250 | $3,858 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $13,500 | $3,791 | 28.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 81 | 86 | $25,800 | $3,752 | 14.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 101 | 178 | $17,800 | $3,726 | 20.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 41 | 53 | $9,750 | $3,325 | 34.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 15 | 16 | $9,600 | $2,750 | 28.7% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 134 | 181 | $9,050 | $2,713 | 30.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 90 | 90 | $4,500 | $2,484 | 55.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 32 | 42 | $6,300 | $2,324 | 36.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,100 | $2,319 | 45.5% |
About Dr. Solomon Forouzesh, M.D
Dr. Solomon Forouzesh, M.D is a Rheumatology healthcare provider based in Culver City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457548133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Solomon Forouzesh, M.D has received a total of $183,065 in payments from pharmaceutical and medical device companies, with $7,135 received in 2024. These payments were reported across 1,524 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,128).
As a Medicare-enrolled provider, Forouzesh has provided services to 9,709 Medicare beneficiaries, totaling 26,759 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties General Practice
- Location Culver City, CA
- Active Since 09/26/2007
- Last Updated 09/26/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457548133
Products in Payments
- Otezla (Drug) $99,315
- Humira (Biological) $20,067
- Otezla (Biological) $9,349
- Rasuvo (Drug) $6,661
- COSENTYX (Biological) $2,894
- Enbrel (Biological) $2,726
- RINVOQ (Biological) $2,670
- TREMFYA (Drug) $2,330
- TALTZ (Drug) $1,601
- Cimzia (Drug) $1,402
- HUMIRA (Biological) $1,378
- BENLYSTA (Biological) $1,118
- XELJANZ (Drug) $1,091
- EVENITY (Biological) $988.12
- ACTHAR (Biological) $917.13
- OFEV (Drug) $749.88
- COSENTYX (Drug) $646.87
- Tymlos (Biological) $643.42
- UBRELVY (Drug) $597.35
- SAPHNELO (Biological) $551.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.